Key Takeaways
- In 2021, an estimated 2.7 million people aged 12 or older received treatment for alcohol use disorder (AUD) at a specialty facility
- Only 10.3% of individuals aged 12+ with SUD received any substance use treatment in the past year per 2021 NSDUH data
- Among adults aged 18+ with past-year illicit drug use disorder, 11.1% received treatment in 2021
- The 1-year abstinence rate for opioid use disorder (OUD) patients on buprenorphine is 55%
- Cognitive Behavioral Therapy (CBT) achieves 40-60% sustained recovery in alcohol use disorder over 12 months
- Methamphetamine treatment with contingency management yields 70% negative toxicology at 12 weeks
- 1-year relapse rate for substance use disorder is 40-60%
- Opioid use disorder relapse within 1 week of detox is 80-95% without medication
- Alcohol relapse in first year post-treatment averages 60%
- Economic cost of relapse in US SUD is $740 billion annually including lost productivity
- Annual societal cost of alcohol misuse is $249 billion in healthcare and criminal justice
- Opioid crisis costs US $1.02 trillion yearly in 2017 estimates
- In 2021, 46.3 million US adults aged 12+ had SUD, 14.6% prevalence
- Males had 23.4% past-year SUD rate vs 13.9% females in 2021
- Ages 18-25 had highest SUD rate at 25.0% in 2021 NSDUH
Treatment access remains critically low despite effective options for addiction recovery.
Demographics
Demographics Interpretation
Economic Impact
Economic Impact Interpretation
Recovery Rates
Recovery Rates Interpretation
Relapse Rates
Relapse Rates Interpretation
Treatment Access
Treatment Access Interpretation
Sources & References
- Reference 1SAMHSAsamhsa.govVisit source
- Reference 2CDCcdc.govVisit source
- Reference 3KFFkff.orgVisit source
- Reference 4NCBIncbi.nlm.nih.govVisit source
- Reference 5PUBLICHEALTHpublichealth.va.govVisit source
- Reference 6HUDUSERhuduser.govVisit source
- Reference 7BOPbop.govVisit source
- Reference 8SHRMshrm.orgVisit source
- Reference 9ASAMasam.orgVisit source
- Reference 10NIDAnida.nih.govVisit source
- Reference 11NIAAAniaaa.nih.govVisit source
- Reference 12NLIHCnlihc.orgVisit source
- Reference 13NCRGncrg.orgVisit source
- Reference 14NEJMnejm.orgVisit source
- Reference 15OJPojp.govVisit source
- Reference 16ACLUaclu.orgVisit source
- Reference 17ASPEaspe.hhs.govVisit source
- Reference 18ALTARUMaltarum.orgVisit source
- Reference 19FSMBfsmb.orgVisit source





